Literature DB >> 20201800

Secretory production of recombinant proteins in Escherichia coli.

Sung Ho Yoon1, Seong Keun Kim, Jihyun F Kim.   

Abstract

Extracellular production of heterologous proteins using the Escherichia coli cell factory offers several advantages over intracellular production and mammalian culture. Properly folded proteins can be rapidly accumulated in the culture media, and downstream processes for isolation and purification can be much simplified. Efforts to enhance the secretory production of target proteins can be largely classified as selection and modification of the signal peptide, co-expression of proteins to assist translocation and folding, improvement of periplasmic release, and protection of target proteins from degradation and contamination. Here, we review recent patents on the secretory production of recombinant proteins in E. coli.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201800     DOI: 10.2174/187220810790069550

Source DB:  PubMed          Journal:  Recent Pat Biotechnol        ISSN: 1872-2083


  27 in total

1.  Site-saturation mutagenesis of mutant L-asparaginase II signal peptide hydrophobic region for improved excretion of cyclodextrin glucanotransferase.

Authors:  Abbas Ismail; Rosli Md Illias
Journal:  J Ind Microbiol Biotechnol       Date:  2017-09-18       Impact factor: 3.346

2.  Periplasmic production via the pET expression system of soluble, bioactive human growth hormone.

Authors:  Jonathan T Sockolosky; Francis C Szoka
Journal:  Protein Expr Purif       Date:  2012-11-17       Impact factor: 1.650

3.  Optimization of a Bacillus sp signal peptide for improved recombinant protein secretion and cell viability in Escherichia coli: Is there an optimal signal peptide design?

Authors:  Kheng Oon Low; Mohd Anuar Jonet; Noor Faizah Ismail; Rosli Md Illias
Journal:  Bioengineered       Date:  2012-08-15       Impact factor: 3.269

Review 4.  Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.

Authors:  Hendrik Waegeman; Wim Soetaert
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-08       Impact factor: 3.346

Review 5.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

6.  Effect of cargo size and shape on the transport efficiency of the bacterial Tat translocase.

Authors:  Neal Whitaker; Umesh Bageshwar; Siegfried M Musser
Journal:  FEBS Lett       Date:  2013-02-16       Impact factor: 4.124

7.  Robust preparative-scale extracellular production of hirudin in Escherichia coli and its purification and characterization.

Authors:  Cuicui Huang; Xuerui Zhang; Jia Qu; Ping Zhang; Shuhua Tan
Journal:  J Ind Microbiol Biotechnol       Date:  2012-07-31       Impact factor: 3.346

8.  Construction of an expression vector for production and purification of human somatostatin in Escherichia coli.

Authors:  Sergi Maicas; Ismaïl Moukadiri; Almudena Nieto; Eulogio Valentín
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

9.  A HER2 bispecific antibody can be efficiently expressed in Escherichia coli with potent cytotoxicity.

Authors:  Limin Lin; Li Li; Changhua Zhou; Jing Li; Jiayu Liu; Rui Shu; Bin Dong; Qing Li; Zhong Wang
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

10.  High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfide-rich proteins in E. coli.

Authors:  Hervé Nozach; Carole Fruchart-Gaillard; François Fenaille; Fabrice Beau; Oscar Henrique Pereira Ramos; Badreddine Douzi; Natalie J Saez; Mireille Moutiez; Denis Servent; Muriel Gondry; Robert Thaï; Philippe Cuniasse; Renaud Vincentelli; Vincent Dive
Journal:  Microb Cell Fact       Date:  2013-04-22       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.